User menu

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

Bibliographic reference Zucca, Emanuele ; Conconi, Annarita ; Martinelli, Giovanni ; Bouabdallah, Reda ; Tucci, Alessandra ; et. al. Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.. In: Journal of Clinical Oncology, Vol. 35, no. 17, p. 1905-1912 (2017)
Permanent URL http://hdl.handle.net/2078.1/183989